amiodarone has been researched along with Extramembranous Glomerulopathy in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone is an anti-arrhythmic drug for life-threatening tachycardia, but various adverse effects have been reported." | 1.35 | Amiodarone-related pulmonary mass and unique membranous glomerulonephritis in a patient with valvular heart disease: Diagnostic pitfall and new findings. ( Katayama, T; Kimura, T; Kuramochi, S; Okada, Y; Ueda, Y; Yamada, T; Yoshikawa, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, T | 1 |
| Kuramochi, S | 1 |
| Katayama, T | 1 |
| Yoshikawa, T | 1 |
| Yamada, T | 1 |
| Ueda, Y | 1 |
| Okada, Y | 1 |
1 other study available for amiodarone and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Amiodarone-related pulmonary mass and unique membranous glomerulonephritis in a patient with valvular heart disease: Diagnostic pitfall and new findings.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cytoplasm; Diagnostic Errors; Fatal Outcome; Foam Cells; G | 2008 |